OLUMIANT Logo (EUIPO, 11/25/2015)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OLUMIANT was filed as Figurative mark on 11/25/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/01/2016.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Other leaves #Stylized leaves #Two to four leaves
| Trademark form | Figurative mark |
| File reference | 014826267 |
| Application date | November 25, 2015 |
| Publication date | February 23, 2016 |
| Entry date | June 1, 2016 |
| Expiration date | November 25, 2025 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis and autoimmune diseases and disorders; Pharmaceutical preparations for the diagnosis, prevention and/or treatment of blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes and dyslipidemia; Pharmaceutical preparations for the diagnosis, prevention and/or treatment of endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders and metabolic diseases and disorders; Pharmaceutical preparations for the diagnosis, prevention and/or treatment of migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease and psychiatric disorders; Pharmaceutical preparations for the diagnosis, prevention and/or treatment of sleep disorders and urological disorders; antidepressants; diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical preparations
44
Medical information services in the field of autoimmune diseases and disorders; medical information services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11014826267